NEPH - Latest News
Nephros, Inc. (NEPH), operates in Healthcare / Medical - Instruments & Supplies, trades on NASDAQ.
Market capitalization stands near $39.0M. Trailing twelve-month P/E ratio is 49.34. Beta to the broader market is 1.47.
The article list below shows the most recent NEPH headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent NEPH Headlines
Nephros, Inc. (NEPH) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 8, 2026
Nephros, Inc.
Nephros Announces Financial Results for Quarter Ended March 31, 2026
globenewswire.com - May 7, 2026
SOUTH ORANGE, N. J.
�Nephros Schedules First Quarter 2026 Financial Results Conference Call
prismmediawire.com - Apr 30, 2026
SOUTH ORANGE, NJ, April 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
Nephros Schedules First Quarter 2026 Financial Results Conference Call
globenewswire.com - Apr 30, 2026
SOUTH ORANGE, N. J.
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
prismmediawire.com - Apr 16, 2026
Company targets one of the largest and most complex water safety markets in the U. S.
How News Affects NEPH Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track NEPH's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked NEPH news questions
- What is the latest NEPH news headline?
- The most recent NEPH headline (May 8, 2026) is "Nephros, Inc. (NEPH) Q1 2026 Earnings Call Transcript". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the NEPH news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What NEPH news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual NEPH options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.